Project Details
E.W. "Al" Thrasher
Status: Funded - Open
A Phase II, Randomized, Observer-blinded, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women between Gestational Age 14-34 weeks and Non-Pregnant Women of 16-45 years old
Brittany Kmush, PhD